Antibodies
23 March 2009
Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients18 March 2009
InflaRx Closes Funding to Move Its Complement Antibody Program into Clinical Trials for Sepsis Treatment18 March 2009
Herceptin now shown to significantly prolong the lives of patients with HER2-positive advanced stomach cancer4 March 2009
XOMA Initiates Phase 2a Clinical Trial With XOMA 052 in Patients With Rheumatoid Arthritis3 March 2009
FDA Provides A Positive Review of InNexus Biotechnology Development Plan for Lead Product2 March 2009
Morphotek(R), Inc. Announces Initiation of MORAb-009 Phase II Study in First- Line Treatment of Mesothelioma26 February 2009
Arzerra(TM) (ofatumumab) MAA Accepted by EMEA25 February 2009
Seattle Genetics Completes Enrollment in Lintuzumab Phase IIb Clinical Trial for Patients with Acute25 February 2009
Implicit Licenses Clinical Stage Antibody Program From LillyNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports